Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 8/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | LDHA | P00338 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4478662 | 1.00 | FFAR1 (0.56) | FFAR1KMT2AATMAOC3L3MBTL1 | |
| SCHEMBL27553229 | 0.87 | AOC3 (0.56) | FFAR1KMT2AATMAOC3L3MBTL1 | |
| SCHEMBL27553231 | 0.87 | AOC3 (0.56) | FFAR1KMT2AATMAOC3L3MBTL1 | |
| SCHEMBL9696473 | 0.85 | AKR1C3 (0.60) | FFAR1L3MBTL1MAPT | |
| SCHEMBL6484578 | 0.85 | FFAR1 (0.66) | FFAR1KMT2AATML3MBTL1LDHA | |
| SCHEMBL5468798 | 0.84 | AOC3 (0.57) | FFAR1KMT2AAOC3L3MBTL1ALDH1A1 | |
| SCHEMBL3443782 | 0.84 | L3MBTL1 (0.67) | FFAR1AOC3L3MBTL1ALDH1A1MAPT | |
| SCHEMBL2226074 | 0.83 | L3MBTL1 (0.68) | FFAR1KMT2AATML3MBTL1LDHA | |
| SCHEMBL6807907 | 0.82 | AOC3 (0.51) | FFAR1KMT2AATMAOC3L3MBTL1 | |
| SCHEMBL8077839 | 0.82 | LMNA (0.48) | FFAR1KMT2AL3MBTL1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7498431-B2 | Process for the preparation of chiral azetidinones | FRAMROZE BOMI PATEL | 2009-03-03 | — | — | US | disclosed |
| US-20070129540-A1 | Process for the preparation of chiral azetidinones | OPUS ORGANICS PVT LIMITED (IN) | 2007-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070129540-A1 | Process for the preparation of chiral azetidinones | CYP1B1, ALDH7A1, CYP3A5 | FFAR1 1950/4885KMT2A 4551/4885ATM 4381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.